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ABSTRACT: Diabetes is a disease of genetic and environmental origin. It affects the glucose-insulin endocrine 
metabolic regulatory system due to the malfunction of the insulin producing cells of the pancreas. The purpose of this 
study is to carry out a comparative analysis of the potencies of hunteria umbellata and metformin on Type 1 diabetes 
mellitus using bio-statistical analysis. The period of attaining normal blood glucose level across times was taken into 
consideration as a basis for comparing the efficacy of the oral antidiabetic herbal drug to that of the orthodox antidiabetic 
drug. The biometric analysis of data from five diabetic patients that were placed on herbal treatment were taken daily for 
a period of 3 weeks during which they attained normal fasting blood glucose level of between 70mg and 100mg as 
compared with a recovery period of 8 weeks for the 15 patients treated with metformin 500mg. These results showed that 
hunteria umbellata is more efficacious in the treatment of diabetes mellitus than metformin 500mg.  
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Diabetes mellitus (DM) is a group of metabolic 
conditions characterized by hyperglycemia resulting 
from defects in insulin secretion, insulin action, or 
both, Ezeja et al., (2015). It is a disease in the glucose-
insulin endocrine metabolic regulatory system, in 
which the pancreas either does not release insulin or 
does not properly use insulin to uptake glucose in the 
plasma. This disease is referred to as hyperglycaemia 
(Karamanou et al., 2016; American Diabetes 
Association, 2009). The Hindu scholars in 1500 BC 
described DM as a mysterious disease causing thirst, 
enormous urine output, and wasting away of the body 
with additional effect that flies and ants are attracted to 
the urine of the sufferers (Das and Shah, 2011).  In 250 
BC, Appollonius of Memphis coined diabetes meaning 
‘siphon’, because the disease drains more fluid from 
the body than what a person could consume (Verma, 
2016). During the 17th century, Thomas Willis added 
the term ‘mellitus’ to diabetes because of the extreme 
sweet taste of the urine.  
 
The pioneers in the treatment of DM were Sushruta, 
Arataeus, and Thomas Willis, Karamanou et al., 
(2016). The prevalence of diabetes is increasing 
rapidly worldwide and the World Health Organization 
in 2003 predicted that by 2030 the number of adults 
with diabetes would have doubled worldwide, from 
177 million in 2000 to 370 million. The worldwide 
estimated prevalence of diabetes among adults in 2010 
was 285 million and this value is predicted to rise to 
439 million by 2030, Ozougwu et al., 2013). Diabetes 
does not manifest as a single disease, but as many 
presentations. It is therefore referred to as ‘starvation 
in the midst of plenty’ (Dean and McEntyre, 2004). 
According to Janaka and Luigi (2016), major 
manifestations of diabetes includes: dehydration in the 
body, passing of excessive urine, and body weakness 
at all times.  
 
There exist three types of diabetes mellitus, namely: 
Type 1 diabetes mellitus, Type 2 diabetes mellitus and 
Gestational diabetes mellitus. According to literature, 
glucose utilization and anti-oxidative mechanisms of 
the aqueous hunteria umbellata (HU) seed extract 
have been used in the management of diabetes.  
 
Both orthodox antidiabetic drugs and herbal 
antidiabetic formulas have performed excellently well 
in the treatment of mild cases of DM. In the work of 
Ezeja et al., (2015), rats were injected with freshly 
prepared 150 mg/kg body weight of alloxan 
monohydrates dissolved in sterile cold normal saline, 
given via the intraperitoneal route.  
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Dry seeds of the plant, Hunteria umbellata K. Schum 
(family: Apocynaceae), are highly valued in African 
traditional medicine (ATM) in the treatment of various 
human diseases, including diabetes mellitus and 
obesity. Huntaria umbellata plant is known to the 
Yoruba race as ‘Abeere’ (Adeneye, 2011). In ATM, 
HU plant has wide therapeutic applications spanning 
the local treatment of pains, gastric ulcers, liver 
diseases, obesity, diabetes mellitus to mention but a 
few. Metformin is an oral antidiabetic orthodox drug 
commonly used for the treatment of Type II diabetes 
mellitus (Kaku, 2010; Rojas, 2013). However, its 
effects on patients are derived usually from clinical 
experiments. In their study, a dynamic model of Type 
II diabetes mellitus with the treatment of metformin 
was proposed (Fabietti, 2007). The Type II diabetic 
model is a modification of an existing compartmental 
diabetic model (Al-Akwaa, 2006).  The purpose of this 
study is to carry out a comparative analysis of the 
potencies of hunteria umbellata and metformin on 
Type 1 diabetes mellitus using bio-statistical analysis. 
 
MATERIALS AND METHODS 
Materials used to carry out the biometric analysis 
include: huntaria umbellata seed, metformin 500mg, 
blender, graduated cylinders, coconuts, beakers, cups, 
spoons, water, 1 oz shot glasses, Accu-chek active 
pack comprising of a blood glucose meter, a test strip 
and a lancing device used for taking blood sugar test; 
MatlabR2013a composing of high-level technical 
computing language with interactive environment for 
algorithm development, and data analysis; and 
Microsoft Excel, a Microsoft office tool used to collate 
and manipulate huge volume of data with variants of 
computational features of the data collected. The study 
entails empirical analysis of data collected from a 
population of twenty type II DM patients partitioned 
into two: fifteen were treated with metformin 500mg 
while five were treated with huntaria umbellata.  
 
The huntaria umbellata seeds which has been blended 
to powder form was mixed with coconut water in ratio 
1:5 for 20 minutes. The mixture is then shaken 
vigorously before it is administered on patients in a 
dose of one 1 oz. shot glass taken twice a day within 
eight hours’ time interval (Akinmegha, 2016). While 
the dosage of huntaria umbellata was consistent, that 
of metformin varied with severity of DM commencing 
with one tablet taken religiously twice within an 
interval of eight hours per patient per day (Rojas, 
2013). The empirical data obtained were drawn from 
the monitoring of the blood glucose levels for one 
month and sixteen weeks respectively for the patients 
that were treated with hunteria umbellata and those 
that were place on metformin 500mg. The algorithm 
involved in the monitoring is as follows: 
1). Wash and dry the patients’ hands with warm water 
to help the blood flow; 2). Turn on the meter and 
prepare a test strip as outlined in users’ manual: many 
Accu-Chek meters turn on automatically when a strip 
is inserted. 3). Choose a suitable spot on the finger but 
don't check from the same finger all the time: the side 
of the fingertip may be less painful than the pads. 4. 
Prepare the lancing device according to the user guide 
provided, then lance your fingertip to get a drop of 
blood. 5). Touch and hold the test strip opening to the 
drop until it has absorbed enough blood to begin the 
test. 6). View the test result. 7). Record the results in a 
logbook, and 8). Discard the used lancet properly. 
 
After tabulating the results derived from the 
aforementioned procedure, the clinical data for both 
partitions of the population were normalized using 
Microsoft excel to an initial normal fasting blood 
glucose of 180mg/dl. Data from patients treated with 
hunteria umbellata were as summarized in Table 1, 
and Table 2 contains the corresponding normalized 
data.  
Table 1: hunteria umbellata Data 
Week P1 P2 P3 P4 P5 
0 196 194 201 173 187 
1 172 175 186 169 183 
2 125 128 141 127 143 
3 98 88 98 76 97 
 
Table 2: Normalised Data for Patients treated with hunteria 
umbellata 
Week P1 P2 P3 P4 P5 AVG 
0 180 180 180 180 180 180 
1 172 162 167 176 176 171 
2 115 119 126 132 138 126 
3 93 82 91 79 93 88 
Bio-statistical models were used for results analyses. 
The one-way analysis of variance (ANOVA) and the 
Multi-comparison (‘post hoc’) test were used to 
determine the significance of the drugs and the 
difference between the estimated mean values of drugs 
used by the two treatment groups. In the one-way 
ANOVA, the following parameters were taken into 
consideration 
The significance level (∝ = 0.05 ) 
The null hypothesis: H0 : µ1 = µ2; where  
µ1 = mean period of treatment 1 (Metformin 500mg), 
µ2 = mean period of treatment 2 (hunteria umbellata) 
If the P-value is less than the significance level, it 
rejects the null hypothesis. 
Alternative hypothesis. 
H1: µ1 ≠ µ2  
 
In the post hoc test, the Turkey-Kramer honest 
significant difference (HSD) procedure was 
implemented as default, based on standard studentized 
range distribution. Its implementation is based on 
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optimal results for a balanced one way  ANOVA and 
according to Ostertagová (2013), the HSD test is 
conservative when there are unequal sample 
sizes.  However, HSD test yields no result for two 
samples comparison since two-group case can be 
adequately addressed by a t-test (Zabell, 2008). And 
the t-test and the F-test are equivalent when statistical 
analysis involves only two means to be 
compared, F = t2. 
 
RESULTS AND DISCUSSION 
The results of the study for both treatments were 
encouraging. The graphical details of the patients’ 
responses to treatments in the both cases for hunteria 
umbellata and metformin 500mg is as contained in 
Figure 1. According to the figure, there exists great 
disparity in the behavior of the two graphs. The graph 
of hunteria umbellata is almost a decreasing section of 
a parabola while the graph of metformin 500mg can be 
likened unto a steadily declining plane surface with 
low angle of declination. .The translation of the two 
analogies is that the potency of hunteria umbellata is 
more than twice of that of metformin 500mg in the 
treatment of diabetes mellitus. The literary 
interpretation of the Figure 1 is clear. Metformin cures 
DM in eight weeks while hunteria umbellata achieves 
a more effective result in just three weeks. The 
outcomes of the one way ANOVA affirm the 
aforementioned assertion. Table 3 contains the results 
of the one way ANOVA as produced by MATLAB. 
However, for the purpose of clarity, we have presented 
the results in the traditional format for easy 
interpretation. 
 
Figure 2 is the block diagram for the multi-comparison 
(post hoc) test to establish the validity of the result of 
the one-way ANOVA. The Figure indicated that after 
three weeks the patients treated with hunteria 
umbellata had recovered fully from diabetes mellitus 
while the group being treated with metformin 500mg 
is still in the process of recovery. 
 













Treatments  21493.6 1 21493.6 6.11 0.025 
Error  56256.4 16 3516 - - 
Total  77750 17 - - - 
 
Of concern in Table 3 is the p-value of the distribution. 
The comparison of the p-value to the significance level 
α of the distributions enables us to assess the null 
hypothesis; we therefore determine whether the 
difference between the means are statistically 
significant. In this work, the null hypothesis states that 
the means of the length of treatment for both drugs are 
equal. Usually, a significance level denoted as α or 
alpha of 0.05 is adequate. A significance level of 0.05 
indicates a 5% risk of concluding that a difference 
exists when there is no actual difference. Since the p-
value of 0.025 is less than the significance level of∝	
0.05, we reject the null hypothesis and conclude that 
the periods of treatment of diabetes mellitus based on 
huntaria umbellata and that of metformin 500mg 
indeed have different means.  
 
Table 3 revealed that statistically, there is a significant 
difference in the mean fasting blood glucose (FBG) of 
patients using the two drugs. The effect of the oral 
antidiabetic herbal drug has a high significance 
obtained from the result of the p-value.  
 
In Figure 2, the blue horizontal line indicates 
metformin (clinical data) treatment with estimated 
mean of 131.8889, while the red horizontal line shows 
the huntaria umbellata (Abeere) treatment with 
estimated Mean of 62.7778. 
 
Fig 1: Normalized data from patients placed on hunteria umbellate 
 
Huntaria umbellata (Abeere) takes 3 weeks to attain 
normal FBG. From this study, it can be inferred that 
huntaria umbellata takes an average of 3 weeks to 
attain normal FBG compared to metformin which 
takes an average of 8 weeks, providing a better 
understanding of the herbal formula (Huntaria 
Umbellata) for Diabetes treatment. 
 
The results showed that huntaria umbellata has greater 
efficiency in reducing blood glucose level than that of 
metformin 500mg by a factor of 2.67. 
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Fig 2: Multi-comparison (Post Hoc) Test of Mean FBG difference 
after week 3 
 
The results of the study agree with existing literature. 
Kaku (2010) and Rojas (2013) both attested to the 
efficacy of metformin in the treatment of type II DM 
affirming the period of treatment of between two and 
three months. In the work of Verma, (2016), the 
potency of various plants as viable options to orthodox 
medicines like metformin was established. Another 
advantage of huntaria umbellata over and above 
metformin was the absence of most side effects 
associated with metformin. For instance, patients 
placed on metformin exhibited such symptoms as 
abdominal pains, belching, chest pain, diarrhea, 
headache, nausea and vomiting, runny nose and 
weakness. The only complaint recorded with patients 
treated with hunteria umbellata was extreme bitterness 
which caused one of the patients to vomit seldomly. 
Conclusion: In this work, we have exploited the 
healing properties of hunteria umbellata (abeere) with 
the possibility of exploring same as possible 
prescription for DM patients in hospitals in Africa. The 
study showed the efficacy of the plant in reducing 
blood sugar based on the p-value obtained from the 
one way ANOVA of the mean lengths of treatments of 
patients with DM using huntaria umbellate on one 
group and metformin 500mg on the second group.  
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